¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀº 2023³â 9,864¸¸ ´Þ·¯¿¡¼ 2028³â 1¾ï 3,483¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2023³âºÎÅÍ 2028³â±îÁö CAGRÀº 6.4%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
ÀÇ·á ÁöÃâ Áõ°¡¿Í ½ÉÀå °Ç°¿¡ ´ëÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê°¡ À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀ» µÞ¹Þħ
À¯·´¿¡¼´Â ÀÇ·á¿¡ ´ëÇÑ °øÀû ÁöÃâÀÌ ±¹³» ÁöÃâÀ» ´É°¡ÇÏ´Â ¼Óµµ·Î ´Ã¾î³ª°í ÀÖÁö¸¸, À̰ÍÀº ÁÖ·Î °í¼Òµæ ±¹°¡¿¡¼ÀÇ ÀÏÀÔ´Ï´Ù. Eurostat¿¡ µû¸£¸é 2021³â EU ÀÇ·á¿¡ ´ëÇÑ Á¤ºÎ ÁöÃâ ÃѾ×Àº 1Á¶ 2,839¾ï 8,000¸¸ ´Þ·¯(1Á¶ 1,790¾ï À¯·Î)·Î, ÀÌ Áö¿ªÀÇ GDPÀÇ 8.1%¿¡ ÇØ´çÇÕ´Ï´Ù. EU ȸ¿ø±¹ Áß¿¡¼ °¡Àå ÀÇ·á ÁöÃâÀÌ ¸¹Àº °ÍÀº µ¶ÀÏÀ̸ç, 2020³â¿¡´Â 5,306¾ï ´Þ·¯(4,320¾ï À¯·Î)¿´½À´Ï´Ù. 2À§´Â ÇÁ¶û½º¿¡¼ 3,451¾ï 4,000¸¸ ´Þ·¯(2,810¾ï À¯·Î), 3À§´Â ÀÌÅ»¸®¾Æ¿¡¼ 1,965¾ï 2,000¸¸ ´Þ·¯(1,600¾ï À¯·Î), 4À§´Â ½ºÆäÀο¡¼ 1,473¾ï 9,000¸¸ ´Þ·¯(1,200¾ï À¯·Î)ÀÔ´Ï´Ù. ¶ÇÇÑ, À¯·´À§¿øÈ¸ÀÇ EU4Health ÇÁ·Î±×·¥, Â÷¼¼´ë Àç»ý±â±Ý, Horizon Europe ¿¬±¸±â±ÝÀº ½ÉÇ÷°ü Áúȯ ºÎ´ãÀ» ´Ù·ç°í, ´õ ³ªÀº ½ÉÇ÷°ü °Ç°À» À§ÇÑ EU Çൿ °èȹ¿¡¼ È®ÀÎµÈ ¿¹¹æÃ¥À» ½ÃÇàÇÕ´Ï´Ù. ±×°ÍÀº ½Ã¹ÎÀÇ ½ÉÇ÷°ü °Ç°À» °³¼±ÇÏ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ °èȹÀº ¿¹¹æ°ú Á¶±â ¹ß°ßºÎÅÍ Ä¡·á ¹× Ä¡·á Á¢±Ù, QOL ¹× ±â´É »óÅ¿¡ À̸£±â±îÁö ȯÀÚÀÇ Àüü ¿©ÇàÀ» ´Ù·ç¸ç ¸ðµç ´Ü°è¿¡¼ µðÁöÅÐÈ¿Í Çõ½ÅÀÌ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â °ÍÀ» °í·ÁÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼ ÀÇ·á ÁöÃâ Áõ°¡¿Í ½ÉÀå °Ç°¿¡ ´ëÇÑ Á¤ºÎ ÁÖµµ ³ë·ÂÀº ¾ÕÀ¸·Î ¼ö³â°£ À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀå ±âȸ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå °³¿ä
À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀº µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹ ¹× ±âŸ À¯·´À¸·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ³ëÀÎ Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü Àå¾ÖÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ¸¹Àº ȯÀÚ Áý´Ü°ú ÀÇ·á Àü¹®°¡µé »çÀÌ¿¡¼ ½ÉÀå ÁúȯÀ» Ä¡·áÇÏ´Â Àúħ½À ÀýÂ÷¿¡ ´ëÇÑ ³ôÀº ¼±È£µµ°¡ ¿¹Ãø ±â°£ µ¿¾È ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ª¿¡¼ Á¦Ç° Ãâ½Ã¿Í Á¦Ç° ½ÂÀÎÀÇ ±ÞÁõ°ú ÇÔ²² Áö¿øÀûÀÎ »óȯ Á¤Ã¥°ú Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê°¡ ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ¼öÀͰú ¿¹Ãø(-2028³â)(±Ý¾×)
À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ¼¼ºÐÈ
À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀº ÀûÀÀÁõ, ÃÖÁ¾ »ç¿ëÀÚ ¹× ±¹°¡·Î ±¸ºÐµË´Ï´Ù.
ÀûÀÀÁõÀ» ¹ÙÅÁÀ¸·Î À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀº ÀÏ¹Ý ¸»ÃÊ Ç÷°ü°ú °ü»ó µ¿¸ÆÀ¸·Î ºÐÇҵ˴ϴÙ. °ü»óµ¿¸Æ ºÎ¹®Àº 2023³â À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå¿¡¼ ´õ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
ÃÖÁ¾ »ç¿ëÀÚº°·Î º¸¸é À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀº º´¿ø, Àü¹® Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)·Î ±¸ºÐµË´Ï´Ù. º´¿ø ºÎ¹®Àº 2023³â À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀåÀº ¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ ¹× ±âŸ À¯·´À¸·Î ±¸ºÐµË´Ï´Ù. µ¶ÀÏÀÌ 2023³â À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
Boston Scientific Corp, Integer Holdings Corp, Medtronic Plc, Merit Medical Systems Inc, Nipro Corp, Teleflex Inc, Terumo Corp°¡ À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå¿¡¼ »ç¾÷À» Àü°³ÇÏ´Â ¼±µµ ±â¾÷ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ¿äÁ¡
Á¦3Àå Á¶»ç ¹æ¹ý
- Á¶»ç ¹üÀ§
- 2Â÷ Á¶»ç
- 1Â÷ Á¶»ç
Á¦4Àå À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ½ÃÀå »óȲ
- ¼Ò°³
- À¯·´ PEST ºÐ¼®
- Àü¹®°¡ÀÇ °ßÇØ
Á¦5Àå À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡
- ¸¸¼º Àüü Æó»ö(CTO) Ä¡·á¸¦ À§ÇÑ °æÇÇÀû °ü»óµ¿¸Æ ÀÎÅͺ¥¼Ç(PCI) »ç¿ë Áõ°¡
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ »ç¿ë°ú °ü·ÃµÈ ÇÕº´Áõ°ú °íÀå
- ½ÃÀå ±âȸ
- ÀÇ·á ÁöÃâ Áõ°¡¿Í ½ÉÀå °Ç°¿¡ °üÇÑ Á¤ºÎ ÁÖµµÀÇ ´ëó
- ÇâÈÄÀÇ µ¿Çâ
- ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ºÐ¾ßÀÇ ½ÅÁ¦Ç° ½ÂÀÎ, Ãâ½Ã, ÀÎÁöµµÀÇ ±Þ»ó½Â
- ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ ¿µÇ⠺м®
Á¦6Àå ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå - À¯·´ ºÐ¼®
- À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ¼öÀͰú ¿¹Ãø ºÐ¼®
Á¦7Àå À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå : 2028³â±îÁö ¼öÀͰú ¿¹Ãø-ÀûÀÀÁõº°
- ¼Ò°³
- °ü»óµ¿¸Æ
- ÀÏ¹Ý ¸»ÃÊ Ç÷°ü
Á¦8Àå À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå ºÐ¼® : 2028³â±îÁö ¼öÀͰú ¿¹Ãø - ÃÖÁ¾ »ç¿ëÀÚº°
- ¼Ò°³
- º´¿ø
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- Àü¹® Ŭ¸®´Ð
Á¦9Àå À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå : 2028³â±îÁö ¼öÀͰú ¿¹Ãø - ±¹°¡º° ºÐ¼®
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ±âŸ À¯·´
Á¦10Àå À¯·´ ½ÉÀå ¸¶ÀÌÅ©·ÎÄ«Å×ÅÍ ½ÃÀå : ¾÷°è »óȲ
Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Boston Scientific Corp
- Teleflex Inc
- Medtronic Plc
- Merit Medical Systems Inc
- Nipro Corp
- Terumo Corp
- Integer Holdings Corp
Á¦12Àå ºÎ·Ï
JHS 23.11.17
The Europe cardiac microcatheter market is expected to grow from US$ 98.64 million in 2023 to US$ 134.83 million by 2028. It is estimated to record a CAGR of 6.4% from 2023 to 2028.
Increasing Healthcare Spending and Government Initiatives Regarding Heart Health Fuel Europe Cardiac Microcatheter Market
In Europe, public spending on healthcare has grown faster than domestic spending, but mainly in high-income countries. Eurostat stated that the EU's total government expenditure on healthcare in 2021 was ~US$ 1,283.98 billion (€ 1,179 billion), or 8.1% of the region's GDP. Germany recorded the highest healthcare expenditure among the EU member states, with US$ 530.60 billion (€ 432 billion) in 2020. France recorded the second-highest healthcare expenditure [US$ 345.14 billion (€ 281 billion)], followed by Italy [US$ 196.52 billion (€ 160 billion)] and Spain [US$ 147.39 billion (€ 120 billion)]. Further, the European Commission's EU4Health program, the Next Generation Recovery Funds, and the Horizon Europe Research Funds offer an opportunity to address the burden of cardiovascular diseases and improve the cardiovascular health of citizens by implementing preventative measures identified in an EU Action Plan for better cardiovascular health. This plan covers the overall patient journey, from prevention and early detection to access to care and treatment to quality of life and functioning status, considering the vital role of digitization and innovation at all stages. Therefore, increasing healthcare spending and government-led initiatives regarding heart health are expected to provide an opportunity for the Europe cardiac microcatheter market growth in the coming years.
Europe Cardiac Microcatheter Market Overview
The Europe cardiac microcatheter market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Key factors driving the regional market growth are rising geriatric population and growing prevalence of cardiovascular disorders. The high preference for minimally invasive procedures among a large patient population and healthcare professionals to treat cardiac disorders is expected to promote the cardiac microcatheter market growth during the forecast period. Furthermore, supportive reimbursement policies and government initiatives, along with a surge in product launches and product approvals in the region, are expected to drive the market growth in the future.
Europe Cardiac Microcatheter Market Revenue and Forecast to 2028 (US$ Million)
Europe Cardiac Microcatheter Market Segmentation
The Europe cardiac microcatheter market is segmented into indication, end user, and country.
Based on indication, the Europe cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the Europe cardiac microcatheter market in 2023.
Based on end user, the Europe cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the Europe cardiac microcatheter market in 2023.
Based on country, the Europe cardiac microcatheter market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe cardiac microcatheter market in 2023.
Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; Teleflex Inc; and Terumo Corp are the leading companies operating in the Europe cardiac microcatheter market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe cardiac microcatheter market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe cardiac microcatheter market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Europe Cardiac Microcatheter Market - by Indication
- 1.3.2 Europe Cardiac Microcatheter Market - by End User
- 1.3.3 Europe Cardiac Microcatheter Market - by Country
2. Europe Cardiac Microcatheter Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Cardiac Microcatheter Market - Market Landscape
- 4.1 Overview
- 4.2 Europe PEST Analysis
- 4.3 Experts' Opinion
5. Europe Cardiac Microcatheter Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Cardiovascular Diseases
- 5.1.2 Growing Use of Percutaneous Coronary Intervention (PCI) for Treating Chronic Total Occlusions (CTO)
- 5.2 Market Restraints
- 5.2.1 Complications and Failures Related to Usage of Cardiac Microcatheter
- 5.3 Market Opportunity
- 5.3.1 Increasing Healthcare Spending and Government-led Initiatives Regarding Heart Health
- 5.4 Future Trends
- 5.4.1 Surge in New Product Approvals, Launches, and Awareness in Field of Cardiac Microcatheter
- 5.5 Impact Analysis of Drivers and Restraints
6. Cardiac Microcatheter Market - Europe Analysis
- 6.1 Europe Cardiac Microcatheter Market Revenue Forecast and Analysis
7. Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 - by Indication
- 7.1 Overview
- 7.2 Coronary
- 7.2.1 Overview
- 7.2.2 Coronary: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3 General Peripheral Vascular
- 7.3.1 Overview
- 7.3.2 General Peripheral Vascular: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Cardiac Microcatheter Market Analysis - by End User
- 8.1 Overview
- 8.2 Hospitals
- 8.2.1 Overview
- 8.2.2 Hospitals: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Overview
- 8.3.2 Ambulatory Surgical Centers: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 - Country Analysis
- 9.1 Overview
- 9.1.1 Europe Cardiac Microcatheter Market, by Country, 2022 & 2028 (%)
- 9.1.1.1 UK: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 Overview
- 9.1.1.1.2 UK: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.3 UK: Europe Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.1.1.4 UK: Europe Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.2 Germany: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Overview
- 9.1.1.2.2 Germany: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.3 Germany: Europe Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.1.2.4 Germany: Europe Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.3 France: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 Overview
- 9.1.1.3.2 France: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.3 France: Europe Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.1.3.4 France: Europe Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.4 Italy: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.4.1 Overview
- 9.1.1.4.2 Italy: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.4.3 Italy: Europe Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.1.4.4 Italy: Europe Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.5 Spain: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.5.1 Overview
- 9.1.1.5.2 Spain: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.5.3 Spain: Europe Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.1.5.4 Spain: Europe Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
- 9.1.1.6 Rest of Europe: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.6.1 Overview
- 9.1.1.6.2 Rest of Europe: Europe Cardiac Microcatheter Market - Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.6.3 Rest of Europe: Europe Cardiac Microcatheter Market, by Indication, 2020-2028 (US$ Million)
- 9.1.1.6.4 Rest of Europe: Europe Cardiac Microcatheter Market, by End User, 2020-2028 (US$ Million)
10. Europe Cardiac Microcatheter Market - Industry Landscape
- 10.1 Overview
- 10.2 Organic Developments
11. Company Profiles
- 11.1 Boston Scientific Corp
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Teleflex Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 Medtronic Plc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Merit Medical Systems Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Nipro Corp
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Terumo Corp
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Integer Holdings Corp
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms